Right subclavian approach as a feasible alternative for transcatheter aortic valve implantation with the CoreValve ReValving System

EuroIntervention

Volumn 8, Issue 6, 2012, Pages 685-690

  Testa, Luca ^a   Brambilla, Nedy ^a   Laudisa, Maria Luisa ^a   De Carlo, Marco ^b   Lanotte, Stefania ^a   Latini, Roberto Adriano ^a   Pizzocri, Samuele ^a   Casavecchia, Matteo ^a   Agnifili, Mauro Luca ^a   Giannini, Cristina ^b   Bortolotti, Uberto ^b   Petronio, Anna Sonia ^b   Bedogni, Francesco ^a  

^a Istituto Clinico S Ambrogio   (Italy)

^b UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

Difficult access; Right subclavian artery; TAVI

Indexed keywords

AGED; ARTERY DISEASE; ARTICLE; ATRIOVENTRICULAR BLOCK; CARDIOVASCULAR MORTALITY; CLINICAL EFFECTIVENESS; DEMOGRAPHY; FEMALE; FEMORAL ARTERY; FOLLOW UP; HUMAN; IMPLANTED HEART PACEMAKER; INCIDENCE; INTERMETHOD COMPARISON; LEFT SUBCLAVIAN ARTERY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT SAFETY; RIGHT SUBCLAVIAN ARTERY; SUBCLAVIAN ARTERY; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT CONTRAINDICATION; TREATMENT RESPONSE; VASCULAR ACCESS;

AGED; AGED, 80 AND OVER; AORTIC VALVE; BIOPROSTHESIS; CARDIAC CATHETERIZATION; CHI-SQUARE DISTRIBUTION; FEASIBILITY STUDIES; FEMALE; FEMORAL ARTERY; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; ITALY; MALE; PROSTHESIS DESIGN; RADIOGRAPHY, INTERVENTIONAL; RETROSPECTIVE STUDIES; SUBCLAVIAN ARTERY; TIME FACTORS; TREATMENT OUTCOME;

EID: 84872138332     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV8I6A107     Document Type: Article

References (12)

1. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S; PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597-607.
2. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ; PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187-98.
3. Petronio AS, De Carlo M, Bedogni F, Marzocchi A, Klugmann S, Maisano F, Ramondo A, Ussia GP, Ettori F, Poli A, Brambilla N, Saia F, De Marco F, Colombo A. Safety and efficacy of the subclavian approach for transcatheter aortic valve implantation with the CoreValve revalving system. Circ Cardiovasc Interv. 2010;3:359-66.
4. Godino C, Maisano F, Montorfano M, Latib A, Chieffo A, Michev I, Al-Lamee R, Bande M, Mussardo M, Arioli F, Ielasi A, Cioni M, Taramasso M, Arendar I, Grimaldi A, Spagnolo P, Zangrillo A, La Canna G, Alfieri O, Colombo A. Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and CoreValve devices in a single center: the Milan experience. JACC Cardiovasc Interv. 2010;3:1110-21.
5. Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein AP, Krucoff MW, Mack M, Mehran R, Miller C, Morel MA, Petersen J, Popma JJ, Takkenberg JJ, Vahanian A, van Es GA, Vranckx P, Webb JG, Windecker S, Serruys PW. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J. 2011;32:205-17.
6. Zahn R, Gerckens U, Grube E, Linke A, Sievert H, Eggebrecht H, Hambrecht R, Sack S, Hauptmann KE, Richardt G, Figulla HR, Senges J; German Transcatheter Aortic Valve Interventions-Registry Investigators. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J. 2011;32:198-204.
7. Eltchaninoff H, Prat A, Gilard M, Leguerrier A, Blanchard D, Fournial G, Iung B, Donzeau-Gouge P, Tribouilloy C, Debrux JL, Pavie A, Gueret P; FRANCE Registry Investigators. Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Eur Heart J. 2011;32:191-7.
8. Bosmans JM, Kefer J, De Bruyne B, Herijgers P, Dubois C, Legrand V, Verheye S, Rodrigus I; Belgian TAVI Registry Participants. Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: results of the Belgian national registry. Interact Cardiovasc Thorac Surg. 2011;12:762-7.
9. Tamburino C, Capodanno D, Ramondo A, Petronio AS, Ettori F, Santoro G, Klugmann S, Bedogni F, Maisano F, Marzocchi A, Poli A, Antoniucci D, Napodano M, De Carlo M, Fiorina C, Ussia GP. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation. 2011;123:299-308.
10. Wenaweser P, Pilgrim T, Roth N, Kadner A, Stortecky S, Kalesan B, Meuli F, Büllesfeld L, Khattab AA, Huber C, Eberle B, Erdös G, Meier B, Jüni P, Carrel T, Windecker S. Clinical outcome and predictors for adverse events after transcatheter aortic valve implantation with the use of different devices and access routes. Am Heart J. 2011;161:1114-24.
11. Lange R, Bleiziffer S, Piazza N, Mazzitelli D, Hutter A, Tassani-Prell P, Laborde JC, Bauernschmitt R. Incidence and treatment of procedural cardiovascular complications associated with trans-arterial and trans-apical interventional aortic valve implantation in 412 consecutive patients. Eur J Cardiothorac Surg. 2011;40:1105-13.
12. Bruschi G, De Marco F, Fratto P, Oreglia J, Colombo P, Botta L, Klugmann S, Martinelli L. Alternative approaches for transcatheter self-expanding aortic bioprosthetic valves implantation: single-center experience. Eur J Cardiothorac Surg. 2011;39:151-8.